Bostal, LLC
Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees
AustarPharma, LLC is an emerging and innovative pharmaceutical company with focus on the drug delivery and generic drug products.
Emerging Market Potential As a rapidly growing pharmaceutical manufacturer with revenue between 25M and 50M, AustarPharma presents opportunities to support their expansion needs through manufacturing technology upgrades, supply chain enhancements, or regulatory compliance solutions.
Innovation Focus AustarPharma’s emphasis on drug delivery and generic products indicates an openness to innovative formulations and assistance in developing advanced delivery systems or patent-expiring generic drug opportunities.
Mid-Size Partner With a small team of 11-50 employees, the company may benefit from scalable business solutions, streamlined automation tools, or consulting services to accelerate growth without increasing overhead.
Technology Stack Insights Utilizing diverse technologies including Microsoft, Apache, and ASP.NET suggests a technology-forward approach, providing openings to offer integration services, cybersecurity solutions, or cloud infrastructure support.
Competitive Positioning Positioned alongside industry giants like Lonza and Thermo Fisher Scientific, AustarPharma might seek strategic partnerships, contract manufacturing, or supply chain efficiencies to strengthen its market position against larger competitors.
Bostal, LLC uses 8 technology products and services including Amazon Web Services, Sage, Microsoft, and more. Explore Bostal, LLC's tech stack below.
| Bostal, LLC Email Formats | Percentage |
| First.Last@austarpharma.com | 98% |
| FLast@austarpharma.com | 1% |
| First@austarpharma.com | 1% |
Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees
AustarPharma, LLC is an emerging and innovative pharmaceutical company with focus on the drug delivery and generic drug products.
Bostal, LLC's revenue is estimated to be in the range of $25M$50M
Bostal, LLC's revenue is estimated to be in the range of $25M$50M